These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11727549)

  • 1. Restenosis and gene therapy.
    Quarck R; Holvoet P
    Expert Opin Biol Ther; 2001 Jan; 1(1):79-91. PubMed ID: 11727549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of cyclin G1 expression by retrovirus-mediated antisense gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation.
    Zhu NL; Wu L; Liu PX; Gordon EM; Anderson WF; Starnes VA; Hall FL
    Circulation; 1997 Jul; 96(2):628-35. PubMed ID: 9244236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innovative erythrocyte-based carriers for gene delivery in porcine vascular smooth muscle cells: basis for local therapy to prevent restenosis.
    Lande C; Cecchettini A; Tedeschi L; Taranta M; Naldi I; Citti L; Trivella MG; Grimaldi S; Cinti C
    Cardiovasc Hematol Disord Drug Targets; 2012 Sep; 12(1):68-75. PubMed ID: 22746344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of MAPK-activated protein kinase 2 (MK2) prevents adverse remodelling and promotes endothelial healing after arterial injury.
    Kapopara PR; von Felden J; Soehnlein O; Wang Y; Napp LC; Sonnenschein K; Wollert KC; Schieffer B; Gaestel M; Bauersachs J; Bavendiek U
    Thromb Haemost; 2014 Dec; 112(6):1264-76. PubMed ID: 25120198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of restenosis with antioxidants: mechanisms and implications.
    Tardif JC; Grégoire J; L'Allier PL
    Am J Cardiovasc Drugs; 2002; 2(5):323-34. PubMed ID: 14727962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for restenosis--what now, what next?
    Appleby CE; Kingston PA
    Curr Gene Ther; 2004 Jun; 4(2):153-82. PubMed ID: 15180583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense therapy for restenosis following percutaneous coronary intervention.
    Kipshidze N; Tsapenko M; Iversen P; Burger D
    Expert Opin Biol Ther; 2005 Jan; 5(1):79-89. PubMed ID: 15709911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligonucleotide-based molecular therapy for restenosis after angioplasty.
    Aoki M; Morishita R; Ogihara T
    Curr Drug Targets; 2003 Nov; 4(8):613-8. PubMed ID: 14577651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of a constitutively active protein kinase G mutant reduces neointima formation and in-stent restenosis.
    Sinnaeve P; Chiche JD; Gillijns H; Van Pelt N; Wirthlin D; Van De Werf F; Collen D; Bloch KD; Janssens S
    Circulation; 2002 Jun; 105(24):2911-6. PubMed ID: 12070122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CXCR4 antagonist POL5551 is equally effective as sirolimus in reducing neointima formation without impairing re-endothelialisation.
    Hamesch K; Subramanian P; Li X; Dembowsky K; Chevalier E; Weber C; Schober A
    Thromb Haemost; 2012 Feb; 107(2):356-68. PubMed ID: 22234341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stent-based delivery of adeno-associated viral vectors with sustained vascular transduction and iNOS-mediated inhibition of in-stent restenosis.
    Fishbein I; Guerrero DT; Alferiev IS; Foster JB; Minutolo NG; Chorny M; Monteys AM; Driesbaugh KH; Nagaswami C; Levy RJ
    Gene Ther; 2017 Nov; 24(11):717-726. PubMed ID: 28832561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs for Restenosis and Thrombosis After Vascular Injury.
    Gareri C; De Rosa S; Indolfi C
    Circ Res; 2016 Apr; 118(7):1170-84. PubMed ID: 27034278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
    Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense strategies to inhibit restenosis.
    Lee M; Simon AD; Stein CA; Rabbani LE
    Antisense Nucleic Acid Drug Dev; 1999 Oct; 9(5):487-92. PubMed ID: 10555157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
    Jaschke B; Milz S; Vogeser M; Michaelis C; Vorpahl M; Schömig A; Kastrati A; Wessely R
    FASEB J; 2004 Aug; 18(11):1285-7. PubMed ID: 15180955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local adventitial anti-angiogenic gene therapy reduces growth of vasa-vasorum and in-stent restenosis in WHHL rabbits.
    Hytönen JP; Taavitsainen J; Laitinen JTT; Partanen A; Alitalo K; Leppänen O; Ylä-Herttuala S
    J Mol Cell Cardiol; 2018 Aug; 121():145-154. PubMed ID: 30003882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for coronary restenosis: is the enthusiasm justified?
    O'Sullivan M; Bennett MR
    Heart; 2001 Nov; 86(5):491-3. PubMed ID: 11602536
    [No Abstract]   [Full Text] [Related]  

  • 18. Gene therapy of fibroproliferative vasculopathies: current ideas in molecular mechanisms and biomedical technology.
    Mitra AK; Agrawal DK
    Pharmacogenomics; 2006 Dec; 7(8):1185-98. PubMed ID: 17184206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutting balloon combined with paclitaxel-eluting balloon for treatment of in-stent restenosis.
    Kong J; Hou J; Ma L; Xing L; Jia H; Liu H; Zhang S; Yu B; Jang IK
    Arch Cardiovasc Dis; 2013 Feb; 106(2):79-85. PubMed ID: 23527911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neointimal growth can be influenced by local adventitial gene manipulation via a needle injection catheter.
    Huehns TY; Krausz E; Mrochen S; Schmid M; Engelmann MG; Esin S; Schrittenloher PK; Höfling B; Günzburg WH; Nikol S
    Atherosclerosis; 1999 May; 144(1):135-50. PubMed ID: 10381287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.